2019. Sep

Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment.

Sci Rep. 2019

Kim HJ, Kim BG, Park JE, Ki CS, Huh J, Youm JB, Kang JS, Cho H.

Green Cross Genome Corporation I  Representative: KI CHANG SEOK   I   Business Registration No. 142-81-61687

107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea

Email. info.gcgenome@gccorp.com  I  Tel. +82 31-280-9939   I    Fax. +82 31-260-9087

©2020 by GC Genome.